Finance

Beta
Lists
SANA:NASDAQ
Sana Biotechnology Inc
၄.၀၁ US$
+၁၂.၆၄%
(+၀.၄၅) 1D
၄.၀၂ US$
+၀.၂၅% (+၀.၀၁၀၀)
Pre-market
Closed: ဇူ ၂, GMT-၄ ၁၆:၀၀:၀၀  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SANA...
Open
၃.၆၀ US$
High
၄.၀၂ US$
Low
၃.၆၀ US$
Mkt. cap
၁၁၁.၅၉ ဋေ
Avg. vol.
၃.၈၂ သန်း
Volume
၁.၉၆ ထောင်
52-wk high
၆.၅၅ US$
52-wk low
၂.၆၁ US$
EPS
-၀.၉၄ US$
Beta
၂.၁၄
Shares outstanding
၂၇.၈၃ ကုဋေ
No. of employees
၁၄၂
Open
၃.၆၀ US$
High
၄.၀၂ US$
Low
၃.၆၀ US$
Mkt. cap
၁၁၁.၅၉ ဋေ
Avg. vol.
၃.၈၂ သန်း
Volume
၁.၉၆ ထောင်
52-wk high
၆.၅၅ US$
52-wk low
၂.၆၁ US$
EPS
-၀.၉၄ US$
Beta
၂.၁၄
Shares outstanding
၂၇.၈၃ ကုဋေ
No. of employees
၁၄၂
News stories
From sources across the web
https://www.dars.gov.et/
https://www.dars.gov.et/
·
ပြီးခဲ့သည့် ၁ ပတ်
SANA Q1 2026 Earnings: Narrower-Than-Expected Loss Drives Positive Surprise - Surprise Factor Analysis
About Sana Biotechnology Inc
CEOSteve Harr
Employees၁၄၂
Founded၂၀၁၈
Headquartersဆီအက်တယ်, ဝါရှင်တန်ပြည်နယ်, ယူနိုက်တက်စတိတ်
Sector-
Websitesana.com
Analyst ratings
Based on 6 analysts giving stock ratings to SANA in the past 3 months
Strong buy
Buy
6
Hold
0
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for SANA in the last 3 months.
Highest
Current ၄.၀၁ US$
၁၆.၀၀ US$ (+၂၉၉.၀၀%)
Average
၉.၈၀ US$ (+၁၄၄.၃၉%)
Lowest
၇.၀၀ US$ (+၇၄.၅၆%)
Analyst
Recommendation
Action
Price target
Projected
Date
Maxwell Skor
Morgan Stanley
Buy
Maintained
၁၂.၀၀ US$
+၁၉၉.၃%
05/18/2026
Martin Fan
Wedbush
Buy
Maintained
၇.၀၀ US$
+၇၄.၆%
05/13/2026
Alec Stranahan
Bank of America Securities
Buy
Reiterated
၇.၀၀ US$
+၇၄.၆%
05/12/2026
Emily Bodnar
H.C. Wainwright
Buy
Reiterated
၇.၀၀ US$
+၇၄.၆%
05/12/2026
Marc Frahm
TD Cowen
Buy
Maintained
-
-
05/11/2026
Michael King
Rodman & Renshaw
Buy
Initiated
၁၆.၀၀ US$
+၂၉၉%
05/11/2026
Samantha Semenkow
Citi
Buy
Maintained
၁၂.၀၀ US$
+၁၉၉.၃%
03/04/2026
Last report
၂၀၂၆ မေ ၁၁
Fiscal period
Q1 2026
EPS / Est. (USD)
-၀.၁၄ US$ / -၀.၁၅ US$
+၄.၅၅%beat
Revenue / Est. (USD)
- / ၀.၀၀
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
၂၀၂၅ ဇွန်
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
၃.၃၇ ကုဋေ
၃.၅၂ ကုဋေ
၄.၀၄ ကုဋေ
၂.၆၄ ကုဋေ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၁.၀၃ ကုဋေ
၁.၀၃ ကုဋေ
၁.၂၂ ကုဋေ
၁.၁၅ ကုဋေ
Operating expense
၄.၄၁ ကုဋေ
၄.၅၅ ကုဋေ
၅.၂၆ ကုဋေ
၃.၇၉ ကုဋေ
Total operating expenses
၄.၄၁ ကုဋေ
၄.၅၅ ကုဋေ
၅.၂၆ ကုဋေ
၃.၇၉ ကုဋေ
Operating income
-၄.၄၁ ကုဋေ
-၄.၅၅ ကုဋေ
-၅.၂၆ ကုဋေ
-၃.၇၉ ကုဋေ
Other non operating income
၅.၉၈ သိန်း
၃.၆၀ သိန်း
၃.၄၀ သန်း
၄.၅၃ သိန်း
EBT including unusual items
-၉.၃၈ ကုဋေ
-၄.၂၂ ကုဋေ
-၅.၈၈ ကုဋေ
-၄.၇၂ ကုဋေ
EBT excluding unusual items
-၄.၂၉ ကုဋေ
-၄.၄၁ ကုဋေ
-၄.၇၉ ကုဋေ
-၃.၆၅ ကုဋေ
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-၉.၃၈ ကုဋေ
-၄.၂၂ ကုဋေ
-၅.၈၈ ကုဋေ
-၄.၇၂ ကုဋေ
Net profit margin
-
-
-
-
Earnings per share
-၀.၁၆
-၀.၁၅
-၀.၁၆
-၀.၁၄
Interest and investment income
၅.၇၇ သိန်း
၁.၀၀ သန်း
၁.၂၈ သန်း
၉.၅၁ သိန်း
Interest expense
-
-
-
-
Net interest expenses
၅.၇၇ သိန်း
၁.၀၀ သန်း
၁.၂၈ သန်း
၉.၅၁ သိန်း
Depreciation and amortization charges
-
-
-
-
EBITDA
-၄.၁၂ ကုဋေ
-၄.၂၃ ကုဋေ
-၄.၉၆ ကုဋေ
-၃.၅၅ ကုဋေ
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer